Neuroblastoma
📧 Sign up to get email alerts when something new happens for Neuroblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma [Phase 1]
A Phase 1 study evaluating irinotecan in combination with bortezomib in children with recurrent or refractory neuroblastoma has been complet…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas [Phase 1]
This Phase I trial evaluated the combination of vorinostat and bortezomib in pediatric patients with refractory or recurrent solid tumors, i…
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma [Phase 3]
A Phase 3 trial comparing combination chemotherapy and surgery with or without isotretinoin in young patients with neuroblastoma has complet…
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma [Phase 3]
Phase 3 trial comparing two myeloablation regimens in pediatric high-risk neuroblastoma patients undergoing stem cell transplant; trial comp…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia [Phase 2]
Phase 2 clinical trial update evaluating alisertib in pediatric patients with various recurrent or refractory solid tumors and leukemia; stu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy [Phase 3]
Phase 3 trial evaluating sodium thiosulfate to prevent cisplatin-induced hearing loss in young patients with various pediatric cancers; stud…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone [Phase 1, Phase 2]
Phase 1/2 pediatric trial evaluating dose-ranging and the efficacy/safety of adding plerixafor to standard mobilization regimens versus stan…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma [Phase 1]
A Phase 1 trial evaluating decitabine followed by a cancer antigen vaccine in neuroblastoma and various sarcomas has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant [Phase 3]
A Phase 3 trial of moxifloxacin to prevent bacterial infections in patients who have undergone a donor stem cell transplant was terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma [Phase 3]
A Phase 3 trial evaluating isotretinoin with or without dinutuximab, aldesleukin, and sargramostim after stem cell transplant in patients wi…
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: N2007-01: Ultratrace™ Iobenguane I 131 in Patients With Relapsed/Refractory High-Risk Neuroblastoma [Phase 2]
Phase 2 trial of Ultratrace™ Iobenguane I 131 in relapsed/refractory high-risk neuroblastoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Surgery in Treating Children With Neuroblastoma [Phase 3]
A Phase 3 trial evaluating surgical treatment for pediatric neuroblastoma has completed. The update provides no results in the snippet.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors [Phase 2]
Phase II study of pertuzumab in combination with erlotinib for metastatic or unresectable neuroendocrine tumors was terminated, with results…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9 [NA]
A terminated clinical trial evaluating an iodine-131–labeled monoclonal antibody (8H9) for central nervous system cancers and neuroblastoma …
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma [Phase 1]
Phase 1 study assessing consolidation with busulfan and melphalan plus autologous stem cell transplant after chemotherapy in newly diagnosed…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging
A completed natural history study followed infants with adrenal masses detected prenatally or neonatally to document disease course for adre…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients [NA]
A completed clinical trial evaluating the effectiveness of the neutropenic diet in pediatric oncology patients, including acute lymphoblasti…
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: Combination Chemotherapy Followed by Stem Cell Transplant in High-risk Neuroblastoma Patients [Phase 3]
A Phase 3 trial evaluating combination chemotherapy followed by stem cell transplant in high-risk neuroblastoma has completed enrollment/dat…
-
CLINICAL_TRIALS trial_result · 2016-12-23Clinical Trial Update: Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma [Phase 1]
A Phase 1 study of temsirolimus with valproic acid in children with relapsed neuroblastoma, osteosarcoma, soft tissue sarcoma, or brain tumo…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma [Phase 1]
Phase 1 trial update reporting results for TPI-287 in patients with refractory or recurrent neuroblastoma or medulloblastoma. The study stat…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma [Phase 1, Phase 2]
Phase 1/2 safety and efficacy study of TPI-287 in neuroblastoma and medulloblastoma was terminated. Results were posted on 2016-10-28.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma [Phase 1, Phase 2]
A randomized Phase 1/2 study evaluating TPI-287 for primary refractory or early relapsed neuroblastoma was terminated. Results were posted i…
-
CLINICAL_TRIALS trial_result · 2016-10-19Clinical Trial Update: Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation [Phase 2]
A Phase 2 trial evaluating reduced-intensity stem cell transplantation for children with relapsed neuroblastoma after autologous transplanta…
-
CLINICAL_TRIALS trial_result · 2016-10-03Clinical Trial Update: Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma [Phase 3]
Phase 3 trial evaluating cyclophosphamide and prednisone with or without immunoglobulin for abnormal muscle movements in children with neuro…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma [Phase 2]
Phase 2 trial of intensified MIBG therapy with high-dose chemotherapy and autologous stem cell rescue in high-risk neuroblastoma has complet…